Baxter International Inc. (NYSE: BAX) Long Term Investor Alert: Investigation of potential Wrongdoing

An investigation on behalf of current long-term investors in shares of Baxter International Inc. (NYSE: BAX) concerning potential breaches of fiduciary duties by certain directors was announced.

Investors who are current long term investors in Baxter International Inc. (NYSE: BAX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NYSE: BAX stocks follows a lawsuit filed against Baxter International Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE: BAX stocks, concerns whether certain officers and directors are liable in connection with the allegations made in that lawsuit.

Deerfield, IL based Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. On February 9, 2023, before the market opened, Baxter International Inc. released its fourth quarter and full year 2022 financial results, revealing that the Company did not meet its earning guidance for the year. The Company claimed that "supply chain headwinds continue to weigh on business performance.

Shares of Baxter International Inc. (NYSE: BAX) declined from $62.12 per share on August 19, 2022 to as low as $37.35 per share on March 17, 2023.

According to that complaint filed in the U.S. District Court for the Northern District of Illinois the plaintiff alleges that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 25, 2022 and February 8, 2023, the defendants made false statements and/or concealed that: (i) the Company concealed the true extent of the supply chain problems it was experiencing while simultaneously exaggerating its ability to maintain a healthy supply chain in the face of global pressures; (ii) as a result, the Company's projected earnings were materially misleading during the Class Period; (iii) the foregoing, once revealed, was reasonably likely to have a material negative impact on the Company's financial condition; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times

Those who purchased shares of Baxter International Inc. (NYSE: BAX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.